Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial-Reference-Cited by-同舟云学术

Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial

Published:2020-12 Issue:6 Volume:18 Page:444-451
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Dumont Clément,Baciarello Giulia,Bosset Pierre-Olivier,Lavaud Pernelle,Colomba Emeline,Massard Christophe,Loriot Yohann,Albiges Laurence,Blanchard Pierre,Bossi Alberto,Nenan Soazig,Fizazi Karim

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference35 articles.

1. Prostate cancer: ESMO Consensus Conference Guidelines 2012;Horwich;Ann Oncol,2013

2. Duration of androgen deprivation therapy in high-risk prostate cancer: a randomized phase III trial;Nabid;Eur Urol,2018

3. Systematic review of systemic therapies and therapeutic combinations with local treatments for high-risk localized prostate cancer;Tosco;Eur Urol,2019

4. Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017;Gillessen;Eur Urol,2018

5. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic signature based on S100 calcium-binding protein family members for lung adenocarcinoma and its clinical significance;Computer Methods in Biomechanics and Biomedical Engineering;2024-07-16

2. Combined treatment of high and very high risk prostate cancer: results of neoadjuvant treatment;Research and Practical Medicine Journal;2023-05-18

3. NO-HDAC dual inhibitors;European Journal of Medicinal Chemistry;2022-01

5. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial;Radiotherapy and Oncology;2021-07